Probing silent cerebral infarct pathogenesis in sickle cell disease with cerebrovascular MRI
脑血管MRI探讨镰状细胞病无症状脑梗死发病机制
基本信息
- 批准号:10536405
- 负责人:
- 金额:$ 4.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:4D MRIAcuteAddressAdultAnatomyAreaArteriesBiological MarkersBloodBlood Flow VelocityBlood VesselsBlood flowBrainBrain regionCarbon DioxideCerebral InfarctionCerebral hemisphereCerebrumChildChildhoodCircle of WillisClinicalClinical ProtocolsConflict (Psychology)CoupledCouplingDataDevelopmentDistalFellowshipFour-dimensionalFunctional disorderFutureGoalsHealthHeterogeneityImaging TechniquesImpaired cognitionImpairmentInfarctionIschemiaLeadLearning DisabilitiesLinkMRI ScansMagnetic Resonance ImagingMeasurementMeasuresMethodsNational Research Service AwardsNervous System TraumaNeurologicOxygenPathogenesisPatientsPerformancePrevalencePreventionPreventive therapyProcessProspective StudiesProtocols documentationRecording of previous eventsRiskRisk AssessmentRisk FactorsRoleSchoolsScreening procedureSickle CellSickle Cell AnemiaSourceSpatial DistributionStrokeTestingTissuesTranscranial Doppler UltrasonographyTriageVariantVascular blood supplyVasodilator AgentsWorkblood oxygen level dependentcell injurycerebral arterycerebral hemodynamicscerebrovascularcerebrovascular pathologyclinically relevantcohortcortex mappinghemodynamicshigh riskimprovedindividual patientischemic lesionneglectnovelpre-doctoralpreventresponserisk stratificationscreeningstressorstroke risksuccessultrasound
项目摘要
PROJECT SUMMARY
Children with sickle cell disease are at increased risk for serious cerebrovascular complications. The most
prevalent of these complications are silent cerebral infarcts, focal areas of ischemic tissue damage in the brain
associated with cognitive impairment and poor school performance. Despite the significant consequences of
silent cerebral infarcts, they are often detected after ischemic damage has occurred. Clinical protocols to triage
sickle cell patients utilize ultrasound measurements of blood velocity in large cerebral arteries, with high blood
velocity indicating increased risk for stroke. However, there is conflicting evidence whether high blood velocity is
a risk factor for silent cerebral infarcts. Additionally, therapies prescribed to high-risk patients may not protect
against silent cerebral infarcts. We need improved understanding of the vascular impairments associated with
silent cerebral infarcts in sickle cell disease to better prevent and treat this source of neurological injury.
This work proposes MRI measurements of cerebrovascular reactivity as a novel source of hemodynamic
information related to silent cerebral infarct formation. Cerebrovascular reactivity is the blood flow response to a
dilatory stressor and is measured in smaller vessels in the cortex, making it a more local metric of vascular health
than blood velocity. Previous studies have demonstrated impaired cerebrovascular reactivity in adults and
children with sickle cell disease, indicating reduced ability to increase blood flow to meet oxygen demands and
increased likelihood for ischemia. The aims of this proposal are to: 1) evaluate the relationship between blood
velocity in large cerebral arteries and cerebrovascular reactivity in the cortex, and 2) determine if cerebrovascular
reactivity is altered in brain regions close to silent cerebral infarcts. Aim 1 is a step forward from previous work,
contextualizing cerebrovascular reactivity against the clinical standard for cerebrovascular risk assessment in
sickle cell disease. Aim 2 determines whether this additional information improves our understanding of the
spatial distribution of silent infarcts.
The proposed study will provide a comprehensive assessment of cerebral hemodynamics in children with sickle
cell disease and offer preliminary evidence for cerebrovascular reactivity as a hemodynamic biomarker for silent
cerebral infarct occurrence. A hemodynamic biomarker that is coupled to silent cerebral infarcts could inform the
treatment of sickle cell disease and aid in the development of new preventative therapies. In the long term, the
imaging techniques developed in this proposal could serve as an alternative or complementary MRI screening
tool to stratify for silent cerebral infarct risk more effectively.
项目摘要
镰状细胞疾病的儿童患严重脑血管并发症的风险增加。最多
这些并发症的普遍是无声的脑梗塞,大脑缺血组织损伤的焦点区域
与认知障碍和学校表现不佳有关。尽管有重大后果
沉默的脑梗塞,经常在发生缺血性损害后检测到它们。分类的临床方案
镰状细胞患者利用大脑动脉的血液速度的超声测量
速度表明中风的风险增加。但是,有相互矛盾的证据是否高血速度是
无声脑梗塞的危险因素。此外,向高危患者开处方的疗法可能无法保护
反对无声的脑梗塞。我们需要对与相关的血管障碍的理解有所改善
镰状细胞疾病中的无声脑梗塞可更好地预防和治疗这种神经系统损伤的根源。
这项工作提出了MRI测量的脑血管反应性,作为新型血流动力学来源
与无声脑梗塞形成有关的信息。脑血管反应性是对A的血流反应
扩张胁迫源,并在皮质中的较小血管中进行测量,使其成为血管健康的局部度量标准
比血液速度。先前的研究表明,成人的脑血管反应性受损
患有镰状细胞疾病的儿童,表明增加血液流动以满足氧气需求的能力降低,并且
缺血的可能性增加。该提议的目的是:1)评估血液之间的关系
大脑动脉的速度和皮质中的脑血管反应性,2)确定脑血管是否是否
在接近无声脑梗塞的大脑区域中的反应性改变了。 AIM 1是以前的工作迈出的一步
对脑血管反应性的情境化针对临床标准的脑血管反应性,以评估脑血管风险评估
镰状细胞性贫血症。 AIM 2确定此附加信息是否可以提高我们对
无声梗塞的空间分布。
拟议的研究将对患有镰刀儿童的脑血液动力学进行全面评估
细胞疾病并提供脑血管反应性的初步证据,作为沉默的血流动力学生物标志物
大脑梗塞的发生。与沉默的脑梗塞相连的血液动力学生物标志物可以告知
治疗镰状细胞疾病并有助于开发新的预防疗法。从长远来看
该提案中开发的成像技术可以用作替代或互补的MRI筛选
更有效地分层以确定无声脑梗塞的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kristina Zvolanek其他文献
Kristina Zvolanek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kristina Zvolanek', 18)}}的其他基金
Probing silent cerebral infarct pathogenesis in sickle cell disease with cerebrovascular MRI
脑血管MRI探讨镰状细胞病无症状脑梗死发病机制
- 批准号:
10798118 - 财政年份:2022
- 资助金额:
$ 4.2万 - 项目类别:
相似国自然基金
用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
- 批准号:32301097
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
- 批准号:82300739
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
- 批准号:32371426
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
- 批准号:82302221
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Probing silent cerebral infarct pathogenesis in sickle cell disease with cerebrovascular MRI
脑血管MRI探讨镰状细胞病无症状脑梗死发病机制
- 批准号:
10798118 - 财政年份:2022
- 资助金额:
$ 4.2万 - 项目类别:
Human cerebral blood flow regulation: sex, mechanism, and stress differences
人类脑血流调节:性别、机制和应激差异
- 批准号:
10650368 - 财政年份:2020
- 资助金额:
$ 4.2万 - 项目类别:
Human cerebral blood flow regulation: sex, mechanism, and stress differences
人类脑血流调节:性别、机制和应激差异
- 批准号:
10407466 - 财政年份:2020
- 资助金额:
$ 4.2万 - 项目类别:
4D SSFP MRI for Detecting Functionally Important Coronary Artery Stenosis at Rest
4D SSFP MRI 用于检测静息时具有重要功能的冠状动脉狭窄
- 批准号:
7837299 - 财政年份:2009
- 资助金额:
$ 4.2万 - 项目类别:
4D SSFP MRI for Detecting Functionally Important Coronary Artery Stenosis at Rest
4D SSFP MRI 用于检测静息时具有重要功能的冠状动脉狭窄
- 批准号:
8055423 - 财政年份:2008
- 资助金额:
$ 4.2万 - 项目类别: